0
Upcoming Allied Market Research
2023
Drug Development Services Market

Drug Development Services Market

by Therapeutic Area (Neurology, Cardiovascular Diseases, Digestive System diseases, Oncology, Infectious and Immune System Diseases, Others), by Process (Lead Optimization, Candidate Validation, Target Selection, Target Validation, Hit-To-Lead Identification) and by Type (Biologic Drugs, Biology Services, Drug Metabolism and Pharmacokinetics, Medicinal Chemistry Services, Small Molecule Drugs): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A08431
Pages: NA
Jul 2023 | 1580 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Drug Development Services Market

Request Now !

Drug development service is the proceeding of a new drug. Molecular manipulation, molecular designing, random screening, drug metabolites, and serendipity are the most common methods for drug discovery. Drug developmentreduces the costs and schedules for drug discovery. The methodof drug discovery is used in biotechnology, pharmacology, and medicine to discover and design new medications.Furthermore, drug development service is used to discover and formulate for the pharmaceutical, biotechnology and biopharmaceutical industries. This process involves various steps such as identification of applicants, synthesis, characterization, screening, and assays for therapeutic efficacy.Pharmaceutical drug development services are provided by CROs to pharmaceutical companies. The services include lead identification, drug discovery assistance, project management, clinical trials, and help in the development of drugs. The momentum spent on this market is accredited to the investments in developing drugs that can combat various diseases such as MS, HIV, and cancer.

Drug development servicesare mostly used in paternity testing, forensics, and anthropology with DNA analysis, and disaster victim identification is an important tool for this sector.

COVID-19 scenario analysis:

  • Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs, such as hydroxychloroquine, have witnessed a dramatic surge in demand for the management of COVID-19.
  • Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs as many developed countries are short of these drugs. The pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19.
  • Attributed to such factors, COVID-19 is expected to have a significant impact on the market.

Top impacting factors: Market scenario analysis, trends, drivers and impact analysis

Augmented demand and supply for medicines, technological upgrades, and upswing in the adoption of innovative techniques for discoveriesand increase in the number of patents’ expiry escalate the market growth globally. Increase in R&D activities, healthcare sector developments, rise in awareness among population about chronic diseases, rise in number of contract development, and manufacturers that stimulating drug discovery and rapidly build up the pharmaceutical industry are factors that encourage the growth of the drug development services market. Developing countries are expected to be at the center of this market.

On the other hand, high investment required as capital but low-profit marginsand strict regulations by Food and Drug Administration hamper the growth of the drug development services market. Moreover, healthcare system challenges in underdeveloped and developing countries impede the growth of the drug discovery services market.

New product launches to boost the market

InApril 2019, Charles River and CHDI Foundation Inc. collaborated on drug discovery and development. This collaboration is a five-year extension while they started working together in 2005 for Huntington’s disease.On10 September 2019, Laboratory Corporation (LabCorp) of America Holdings’s inaugurated the Covance Drug Development segment for R&D center in Shanghai, which is the largest in the Asia-Pacific region.Thermo Fisher Scientific introduced KaryoSat assays in stem cell research to accelerate research.On April 9, 2019, Eurofins Discovery announced a new drug discovery service,DiscoveryOne Integrated Drug Services.

Key benefits of the report:

  • This study presents the analytical depiction of the drug development services market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the drug development services market share.
  • The current market is quantitatively analyzed to highlight the drug development services market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the drug development services market research report:

  • Which are the leading market players active in the market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What are the projections for the future that would help in taking further strategic steps?

Drug Development Services Market Report Highlights

Aspects Details
By Therapeutic Area
  • Neurology
  • Cardiovascular Diseases
  • Digestive System diseases
  • Oncology
  • Infectious and Immune System Diseases
  • Others
By Process
  • Lead Optimization
  • Candidate Validation
  • Target Selection
  • Target Validation
  • Hit-To-Lead Identification
By Type
  • Biologic Drugs
  • Biology Services
  • Drug Metabolism and Pharmacokinetics
  • Medicinal Chemistry Services
  • Small Molecule Drugs
By Region
  • North America  (US, Canada)
  • Europe  (Germany, UK, France, rest of Europe)
  • Asia-Pacific  (China, Japan, India, rest of Asia-Pacific)
  • Latin America  (Brazil, Mexico, rest of LATAM)
  • Middle East 
  • Africa 
Key Market Players Albany Molecular Research Inc., Shanghai Medicilon, Biotech Corporation, WuXi AppTec, Evotec SE, Aurigene Discovery Technologies Ltd., Thermo Fisher Scientific, Inc., TCG Lifesciences Pvt. Ltd., Selvita S. A., Eurofins Scientific
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Drug Development Services Market

Start reading.
This Report and over 53,662+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers